Vigilant raises $5.5M in funding
February 25, 2015 -- Vigilant Biosciences has raised $5.5 million in Series B funding. The company intends to use the newly raised funds to get U.S. and European approval for its oral cancer device, the OncAlert oral cancer risk assessment system.
Researchers propose new staging model for HPV+ oropharyngeal cancer
February 24, 2015 -- Canadian researchers are proposing a new tumor-staging model for predicting outcomes and guiding treatments for patients with human papillomavirus (HPV)-related oropharyngeal cancer, according to a new study in the Journal of Clinical Oncology. Since HPV-related cancer differs significantly from smoking-related cancer, less-intensive treatment strategies may be more appropriate, the study found.
Tufts dental school to add oral medicine residency program
February 23, 2015 -- Tufts University School of Dental Medicine will begin enrolling students in its new Advanced Education Program in Oral Medicine in July 2016.
NCI awards $1M grant for 1st heavy ion radiation center in U.S.
February 18, 2015 -- The National Cancer Institute (NCI) has awarded the University of Texas Southwestern a $1 million planning grant to develop research proposals for the first heavy ion radiation therapy research center in the U.S.
New tracer could help HNSCC patients avoid surgery
February 16, 2015 -- With the help of a novel radiotracer, researchers were able to accurately identify sentinel lymph nodes in patients with head and neck squamous cell carcinoma (HNSCC), potentially reducing the number of patients who need to undergo selective neck dissection.
New research suggests possible cure for HPV+ oropharyngeal cancer
February 13, 2015 -- It may be possible for some patients with human papillomavirus-positive oropharyngeal cancer to be cured, even after the disease has spread to other organs, Canadian researchers reported today at the International Conference on Innovative Approaches in Head and Neck Oncology in Nice, France.
Lumina HealthCare offers oral brush biopsy test
February 12, 2015 -- Lumina HealthCare, an onsite dental care services provider based in Los Angeles, has announced that it is now offering the oral brush biopsy diagnostic test.
Study produces 1st comprehensive genomic map of HNC
February 5, 2015 -- Researchers have identified genomic changes in head and neck cancers (HNCs) caused by human papillomavirus (HPV), according to a new study in the journal Nature. The findings could provide detailed explanations of how HPV infection and smoking play roles in HNC risk and disease development and also offer diagnostic and treatment therapies.
Family history of early cancer is HNC risk factor in young adults
February 3, 2015 -- In the largest investigation on the role of major risk factors for head and neck cancers (HNC) in young adults, researchers found that these cancers are more likely the result of inherited factors, rather than lifestyle factors such as smoking or drinking alcohol, according to a new study in the International Journal of Epidemiology.
Study: Heavy smokers should be checked for head/neck cancer
January 22, 2015 -- In addition to being screened for lung cancer, heavy smokers should also be checked for head and neck cancer to improve early detection and survival, according to a new study by University of Pittsburgh researchers in the journal Cancer.
Special Feature
Aspirin can help battle head/neck cancer

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.

VENDOR CONNECT
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection
Conferences
Oral Dermatology and Pathology Alaskan Cruise
June 14-21
Departing Vancouver, British Columbia Canada